R&G PharmaStudies Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 11, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Market Capitalization	7,200	4,756	6,190	4,940	-	-
Market Cap Growth	63.00%	-23.17%	25.30%	-	-	-
Enterprise Value	5,495	3,124	4,564	3,498	-	-
Last Close Price	75.68	49.83	63.89	50.84	-	-
PE Ratio	47.56	33.92	38.09	43.55	-	-
Forward PE	48.36	25.30	-	-	-	-
PS Ratio	9.12	6.39	8.58	7.75	-	-
PB Ratio	3.74	2.59	3.53	3.10	-	-
P/TBV Ratio	3.96	2.75	3.58	3.14	-	-
P/FCF Ratio	120.48	35.29	35.85	45.06	-	-
P/OCF Ratio	85.93	30.73	32.15	37.87	-	-
EV/Sales Ratio	6.96	4.20	6.33	5.49	-	-
EV/EBITDA Ratio	37.72	24.26	29.69	31.68	-	-
EV/EBIT Ratio	40.38	25.81	34.81	33.97	-	-
EV/FCF Ratio	91.94	23.18	26.43	31.90	-	-
Debt / Equity Ratio	0.01	0.04	0.01	0.01	0.03	-
Debt / EBITDA Ratio	0.06	0.51	0.05	0.13	0.08	-
Debt / FCF Ratio	0.16	0.53	0.05	0.14	0.14	-
Net Debt / Equity Ratio	-0.89	-0.93	-0.97	-0.94	-0.80	-0.87
Net Debt / EBITDA Ratio	-12.89	-13.23	-11.03	-13.64	-2.59	-3.11
Net Debt / FCF Ratio	-28.62	-12.65	-9.82	-13.74	-4.60	-15.78
Asset Turnover	0.34	0.34	0.37	0.50	1.01	1.00
Inventory Turnover	7.33	8.04	8.33	8.36	10.43	11.18
Quick Ratio	5.72	4.73	6.20	6.25	2.35	2.32
Current Ratio	5.96	4.88	6.38	6.45	2.58	2.54
Return on Equity (ROE)	8.22%	7.90%	9.73%	11.24%	25.91%	29.07%
Return on Assets (ROA)	3.68%	3.43%	4.14%	5.03%	11.35%	11.30%
Return on Invested Capital (ROIC)	60.57%	113.70%	159.47%	104.63%	136.45%	825.80%
Return on Capital Employed (ROCE)	6.90%	6.40%	7.50%	6.40%	24.60%	26.00%
Earnings Yield	2.10%	2.95%	2.63%	2.30%	-	-
FCF Yield	0.83%	2.83%	2.79%	2.22%	-	-
Dividend Yield	0.21%	0.32%	0.31%	0.31%	-	-
Payout Ratio	10.37%	20.24%	3.58%	-	-	-
Buyback Yield / Dilution	0.87%	0.64%	-16.78%	-14.43%	0.38%	-0.37%
Total Shareholder Return	1.07%	0.96%	-16.46%	-14.12%	0.38%	-0.37%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.